Foote JB, Mattox TE, Keeton AB, Chen X, Smith FT, Berry K, Holmes TW, Wang J, Huang CH, Ward A, Mitra AK, Ramirez-Alcantara V, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Nagaraju GP, Bandi DSR, Maxuitenko YY, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou Get al.(2025) A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer Cancer Res, 85(5), 956-972 DOI 10.1158/0008-5472.CAN-24-0323, PubMed 39700396
Hyldbakk A, Fleten KG, Snipstad S, Åslund AKO, Davies CL, Flatmark K, Mørch Y(2023) Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models Nanomedicine, 48, 102656 DOI 10.1016/j.nano.2023.102656, PubMed 36646195
Ito I, Yousef AMG, Chowdhury S, Dickson PN, Naini ZA, White MG, Fleten KG, Flatmark K, Fournier KF, Fowlkes NW, Shen JP(2023) Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma Cancer Res, 83(19), 3184-3191 DOI 10.1158/0008-5472.CAN-23-0013, PubMed 37433032
